TY - JOUR
T1 - The gut microbiome of heart failure with preserved ejection fraction
AU - Beale, Anna L.
AU - O’Donnell, Joanne A.
AU - Nakai, Michael E.
AU - Nanayakkara, Shane
AU - Vizi, Donna
AU - Carter, Kaye
AU - Dean, Eliza
AU - Ribeiro, Rosilene V.
AU - Yiallourou, Stephanie
AU - Carrington, Melinda J.
AU - Marques, Francine Z.
AU - Kaye, David M.
N1 - Funding Information:
This work was supported by a National Health and Medical Research Council of Australia program grant and fellowship to Prof Kaye, a project grant to A/Prof Marques and Prof Kaye, and a fellowship to Dr O’Donnell. A/Prof Marques is supported by a National Heart Foundation Future Leader Fellowship and National Heart Foundation grants. The Baker Heart & Diabetes Institute is supported in part by the Victorian government’s Operational Infrastructure Support Program.
Publisher Copyright:
© 2021 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2021/7/6
Y1 - 2021/7/6
N2 - BACKGROUND: Risk factors for heart failure with preserved ejection fraction (HFpEF) include hypertension, age, sex, and obesity. Emerging evidence suggests that the gut microbiota independently contributes to each one of these risk factors, potentially mediated via gut microbial-derived metabolites such as short-chain fatty acids. In this study, we determined whether the gut microbiota were associated with HFpEF and its risk factors. METHODS AND RESULTS: We recruited 26 patients with HFpEF and 67 control participants from 2 independent communities. Patients with HFpEF were diagnosed by exercise right heart catheterization. We assessed the gut microbiome by bacterial 16S rRNA sequencing and food intake by the food frequency questionnaire. There was a significant difference in α-diversity (eg, number of microbes) and β-diversity (eg, type and abundance of microbes) between both cohorts of controls and patients with HFpEF (P=0.001). We did not find an association between β-diversity and specific demographic or hemodynamic parameters or risk factors for HFpEF. The Firmicutes to Bacteroidetes ratio, a commonly used marker of gut dysbiosis, was lower, but not significantly so (P=0.093), in the patients with HFpEF. Compared with controls, the gut microbiome of patients with HFpEF was depleted of bacteria that are short-chain fatty acid producers. Consistent with this, participants with HFpEF consumed less dietary fiber (17.6±7.7 versus 23.2±8.8 g/day; P=0.016). CONCLUSIONS: We demonstrate key changes in the gut microbiota in patients with HFpEF, including the depletion of bacteria that generate metabolites known to be important for cardiovascular homeostasis. Further studies are required to validate the role of these gut microbiota and metabolites in the pathophysiology of HFpEF.
AB - BACKGROUND: Risk factors for heart failure with preserved ejection fraction (HFpEF) include hypertension, age, sex, and obesity. Emerging evidence suggests that the gut microbiota independently contributes to each one of these risk factors, potentially mediated via gut microbial-derived metabolites such as short-chain fatty acids. In this study, we determined whether the gut microbiota were associated with HFpEF and its risk factors. METHODS AND RESULTS: We recruited 26 patients with HFpEF and 67 control participants from 2 independent communities. Patients with HFpEF were diagnosed by exercise right heart catheterization. We assessed the gut microbiome by bacterial 16S rRNA sequencing and food intake by the food frequency questionnaire. There was a significant difference in α-diversity (eg, number of microbes) and β-diversity (eg, type and abundance of microbes) between both cohorts of controls and patients with HFpEF (P=0.001). We did not find an association between β-diversity and specific demographic or hemodynamic parameters or risk factors for HFpEF. The Firmicutes to Bacteroidetes ratio, a commonly used marker of gut dysbiosis, was lower, but not significantly so (P=0.093), in the patients with HFpEF. Compared with controls, the gut microbiome of patients with HFpEF was depleted of bacteria that are short-chain fatty acid producers. Consistent with this, participants with HFpEF consumed less dietary fiber (17.6±7.7 versus 23.2±8.8 g/day; P=0.016). CONCLUSIONS: We demonstrate key changes in the gut microbiota in patients with HFpEF, including the depletion of bacteria that generate metabolites known to be important for cardiovascular homeostasis. Further studies are required to validate the role of these gut microbiota and metabolites in the pathophysiology of HFpEF.
KW - 16S
KW - Heart failure with preserved ejection fraction
KW - Microbiome
KW - Microbiota
KW - Short-chain fatty acids
UR - http://www.scopus.com/inward/record.url?scp=85110293414&partnerID=8YFLogxK
U2 - 10.1161/JAHA.120.020654
DO - 10.1161/JAHA.120.020654
M3 - Article
C2 - 34212778
AN - SCOPUS:85110293414
VL - 10
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
SN - 2047-9980
IS - 13
M1 - e020654
ER -